Restoration Of Sensation, Reduced Pain, And Improved Balance In Subjects With Diabetic Peripheral Neuropathy: A Double-Blind, Randomized, Placebo-Controlled Study With Monochromatic Near-Infrared Treatment

Article Summary

In summary, this double-blind, randomized, placebo-controlled study demonstrates that near-infrared treatment with the Anodyne Therapy System (ATS) has a positive impact on individuals with diabetic peripheral neuropathy (DPN).

The treatment improves sensation, reduces pain, and enhances balance in these individuals. These findings highlight near-infrared treatment as an effective therapeutic approach for managing DPN symptoms, providing a potentially beneficial intervention for individuals with this condition.

Read Full Article:   Https://Pubmed.Ncbi.Nlm.Nih.Gov/14693984/

Our Founder

David Christenson is the Founder and CEO of Neurocare Pro, serving medical practices across North America. As an expert in the field, David has been a contributing author on the subject of PBM light therapy in various health care publications. He speaks nationally and internationally on the many uses of PBM light therapy, highlighting the research studies done in the areas of brain health, diabetic peripheral neuropathy, and chronic pain relief.

Helping lead the way to understanding red light therapy

In addition, David regularly consults with health care professionals on Photobiomodulation Advanced Modalities with an emphasis on business development for medical practices.